The Intercontinental Journal of Emergency Medicine aims to publish issues related to all fields of emergency medicine and all specialties involved in the management of emergencies in the hospital and prehospital environment of the highest scientific and clinical value at an international level and accepts articles on these topics.
1. Introduction
The Journal accepts submissions in English, which is the sole language of publication and editorial processing. Manuscripts must be original, approved by all authors, and must not have been previously published or be under consideration elsewhere. All submissions are processed through an online submission system.
2. Manuscript Preparation: General Formatting
Manuscripts must be prepared in Microsoft Word, using A4 paper size with 2.5 cm margins on all sides. Text must be double-spaced in 12-point Times New Roman font. International System of Units (SI) should be used.
The following formatting rules apply:
Text and tables should be in MS Word format. Figures and images should be submitted in JPEG format with a minimum resolution of 300 DPI.
3. Article Types and Requirements
Identification of the correct article type is the first step in submission, as it dictates the specific formatting and word limits.
3.1. Original Article
Presents substantial novel research, including clinical trials, observational studies, diagnostic accuracy studies, systematic reviews, meta-analyses, and experimental studies.
3.2. Case Report / Brief Report
Presents rare cases, novel diagnostic/therapeutic challenges, or preliminary findings.
3.3. Review Article
Provides comprehensive analyses of specific topics. May be invited, but unsolicited submissions are welcomed.
3.4. Letter to the Editor
Offers commentary on articles published in the journal or discusses current developments.
3.5. Editorial Comment
A brief critical commentary, typically invited by the Editor-in-Chief, on a recently published article.
4. Clinical Trials and Reporting Guidelines
Registration of clinical trials in a publicly accessible registry (e.g., ClinicalTrials.gov or a WHO ICTRP primary registry) is encouraged. The registry name and number must be provided at the end of the abstract. Authors are advised to consult the EQUATOR network (http://www.equator-network.org/) for appropriate reporting guidelines.
5. Manuscript Submission
The entire submission process is completed online. The submission should be divided into SEPARATE files:
5.1. Cover Letter
Must include the article title, corresponding author's name, article type, and statements regarding:
5.2. Title Page
A separate file containing:
5.3. Main Document
A blinded file containing, in order:
5.4. Tables
Each table should be submitted as a separate file, numbered consecutively, and cited in the text.
5.5. Figures
Each figure should be uploaded as a separate file in JPEG format (min. 300 DPI). Any identifying information must be blinded.
5.6. Ethics Committee Approval Form
A copy of the ethics committee approval must be provided for all relevant studies, stating the committee name, date, and approval number.
5.7. Copyright Agreement and Acknowledgement of Authorship Form
All authors must meet the ICMJE authorship criteria and sign this form, which is available on the journal’s website.
5.8. ICMJE Conflict of Interest Form
The completed form must be submitted with the manuscript.
6. References
References must follow the AMA-11 style and be numbered consecutively in the order they are cited in the text using superscript Arabic numerals.
Examples:
When there are six or fewer authors, all should be listed. For seven or more, list the first three followed by "et al."
7. ORCID
Providing an ORCID iD for the corresponding author is mandatory. ORCID iDs for all co-authors are strongly recommended. iDs can be registered at https://orcid.org/register.
8. Publication Process
Accepted manuscripts are copy-edited for grammar and style. A PDF proof is sent to the corresponding author for final approval, which must be returned within 48 hours. Articles are published online as "Ahead-of-Print" before inclusion in a scheduled issue.